Gelesis Holdings, Inc.
GLSNYSEHealthcare
$0.16
+$0.00(+0.00%)
Market Cap$11630550
P/E Ratio—
52W High$5.67
52W Low$0.012
Gelesis Holdings, Inc. (GLS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GLS · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2023Report Date: Aug 14, 2023EPS Actual
-$0.10
Revenue
$0.00B
Fiscal Period
Q3 FY2023
FY ends December
Report Date
Aug 14, 2023
After Market Close
GLS reports quarterly as a NYSE-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2024 | Mar 26, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Nov 13, 2023 | — | — | — | — | — | — |
| — Q3 FY2023 | Aug 14, 2023 | — | -$0.10 | — | $0.00B | — | — |
| — Q2 FY2023 | May 10, 2023 | — | -$0.07 | — | $0.00B | — | — |
| ▼ Q1 FY2023 | Mar 28, 2023 | -$0.26 | -$0.33 | -28.1% | $0.00B | — | — |
| ▲ Q4 FY2022 | Nov 14, 2022 | -$0.34 | -$0.20 | +41.2% | $0.01B | — | — |
| — Q3 FY2022 | Sep 16, 2022 | — | -$0.17 | — | $0.01B | — | — |
| — Q2 FY2022 | Jun 23, 2022 | — | -$0.09 | — | $0.01B | — | — |
Q1 FY2024
Mar 26, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 13, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 14, 2023
EPS Actual
-$0.10
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
May 10, 2023
EPS Actual
-$0.07
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2023
Mar 28, 2023Miss
EPS Actual
-$0.33
EPS Est.
-$0.26
EPS Surpr.
-28.1%
Revenue
$0.00B
Q4 FY2022
Nov 14, 2022Beat
EPS Actual
-$0.20
EPS Est.
-$0.34
EPS Surpr.
+41.2%
Revenue
$0.01B
Q3 FY2022
Sep 16, 2022
EPS Actual
-$0.17
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2022
Jun 23, 2022
EPS Actual
-$0.09
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
No analyst estimates available for GLS.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2023 | Aug 14, 2023 | — | $0.01 | — | — |
| — Q2 FY2023 | May 10, 2023 | — | $0.01 | $0.01 | +22.73% |
| ▼ Q1 FY2023 | Mar 28, 2023 | -28.1% | $0.18 | $0.19 | +5.00% |
| ▲ Q4 FY2022 | Nov 14, 2022 | +41.2% | $0.35 | $0.36 | +5.36% |
| — Q3 FY2022 | Sep 16, 2022 | — | $1.15 | $1.13 | -1.74% |
| — Q2 FY2022 | Jun 23, 2022 | — | $1.75 | $1.69 | -3.43% |
| — Q1 FY2022 | Mar 24, 2022 | — | $6.15 | $5.76 | -6.34% |
| — Q3 FY2021 | Sep 30, 2021 | — | No price data | $6.53 | — |
Q3 FY2023—
Report Date
Aug 14, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
—
Q2 FY2023+22.73%
Report Date
May 10, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2023+5.00%
Report Date
Mar 28, 2023
EPS Beat/Miss
-28.1%
Price Before
$0.18
Price After
$0.19
Q4 FY2022+5.36%
Report Date
Nov 14, 2022
EPS Beat/Miss
+41.2%
Price Before
$0.35
Price After
$0.36
Q3 FY2022-1.74%
Report Date
Sep 16, 2022
EPS Beat/Miss
—
Price Before
$1.15
Price After
$1.13
Q2 FY2022-3.43%
Report Date
Jun 23, 2022
EPS Beat/Miss
—
Price Before
$1.75
Price After
$1.69
Q1 FY2022-6.34%
Report Date
Mar 24, 2022
EPS Beat/Miss
—
Price Before
$6.15
Price After
$5.76
Q3 FY2021—
Report Date
Sep 30, 2021
EPS Beat/Miss
—
Price Before
—
Price After
$6.53
Avg Beat Reaction+5.36%
Avg Miss Reaction+5.00%
Beat Rate1 / 8 quarters
Largest Move+22.73% (Q2 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GLS ends December
Gelesis Holdings, Inc. (GLS) most recently reported earnings on August 14, 2023 for Q3 FY2023, posting EPS of $-0.10 (in line with the analyst consensus of —). The next GLS earnings date is expected around September 1, 2026.
Each quarter, investors track GLS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GLS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GLS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GLS earnings · 4 questionsGelesis Holdings, Inc.'s next earnings report is expected around September 1, 2026. GLS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GLS historically reports after market close (AMC).
GLS earnings datewhen is GLS earningsGLS next earnings datewhen does GLS report earningsGLS earnings calendar
▸ Source: FMP · Gelesis Holdings, Inc. SEC filings · US GAAP · Gelesis Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026